BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16933380)

  • 1. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 2006 Aug; 81(34/35):331-40. PubMed ID: 16933380
    [No Abstract]   [Full Text] [Related]  

  • 2. Japanese Encephalitis Vaccine.
    Mileno MD
    R I Med J (2013); 2020 Aug; 103(6):49-50. PubMed ID: 32752568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese Encephalitis Vaccines: WHO position paper – February 2015.
    Wkly Epidemiol Rec; 2015 Feb; 90(9):69-87. PubMed ID: 25726573
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccinating against Japanese encephalitis virus: what have we learned from recent clinical trials?
    Dubischar-Kastner K; Kanesa-Thasan N
    Expert Rev Vaccines; 2012 Oct; 11(10):1159-61. PubMed ID: 23176646
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on Japanese encephalitis vaccine for children: United States, May 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):664-5. PubMed ID: 21617633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese encephalitis virus remains an important cause of encephalitis in Thailand.
    Olsen SJ; Supawat K; Campbell AP; Anantapreecha S; Liamsuwan S; Tunlayadechanont S; Visudtibhan A; Lupthikulthum S; Dhiravibulya K; Viriyavejakul A; Vasiknanonte P; Rajborirug K; Watanaveeradej V; Nabangchang C; Laven J; Kosoy O; Panella A; Ellis C; Henchaichon S; Khetsuriani N; Powers AM; Dowell SF; Fischer M
    Int J Infect Dis; 2010 Oct; 14(10):e888-92. PubMed ID: 20674433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new Japanese encephalitis vaccine (Ixiaro).
    Med Lett Drugs Ther; 2009 Aug; 51(1319):66-7. PubMed ID: 19696707
    [No Abstract]   [Full Text] [Related]  

  • 8. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis.
    Kumar R; Tripathi P; Rizvi A
    N Engl J Med; 2009 Apr; 360(14):1465-6. PubMed ID: 19339732
    [No Abstract]   [Full Text] [Related]  

  • 10. Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).
    Kikukawa A; Gomi Y; Akechi M; Onishi T; Manabe S; Namazue J; Fuke I; Ishikawa T; Okuno Y; Ueda S
    Vaccine; 2012 Mar; 30(13):2329-35. PubMed ID: 22306856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japanese encephalitis. Inactivated Japanese encephalitis virus vaccine.
    Wkly Epidemiol Rec; 1994 Apr; 69(16):113-8. PubMed ID: 8003406
    [No Abstract]   [Full Text] [Related]  

  • 13. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
    [No Abstract]   [Full Text] [Related]  

  • 14. Japanese encephalitis vaccine for travelers: exploring the limits of risk.
    Shlim DR; Solomon T
    Clin Infect Dis; 2002 Jul; 35(2):183-8. PubMed ID: 12087525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expert opinion on vaccination of travelers against Japanese encephalitis.
    Burchard GD; Caumes E; Connor BA; Freedman DO; Jelinek T; Jong EC; von Sonnenburg F; Steffen R; Tsai TF; Wilder-Smith A; Zuckerman J
    J Travel Med; 2009; 16(3):204-16. PubMed ID: 19538583
    [No Abstract]   [Full Text] [Related]  

  • 16. Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?
    Choi UY; Lee SY; Kim KH; Kim DS; Choi KM; Cha SH; Kang JH
    J Trop Pediatr; 2013 Oct; 59(5):423-5. PubMed ID: 23764540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese encephalitis revisited.
    Diagana M; Preux PM; Dumas M
    J Neurol Sci; 2007 Nov; 262(1-2):165-70. PubMed ID: 17643451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine.
    Vadrevu KM; Potula V; Khalatkar V; Mahantshetty NS; Shah A; Ella R
    J Infect Dis; 2020 Oct; 222(9):1478-1487. PubMed ID: 31858116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japanese encephalitis: the need for a more effective vaccine.
    Marfin AA; Gubler DJ
    Lancet; 2005 Oct 15-21; 366(9494):1335-7. PubMed ID: 16226596
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO working group on the quality, safety and efficacy of japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21-23 February 2012.
    Trent DW; Minor P; Jivapaisarnpong T; Shin J;
    Biologicals; 2013 Nov; 41(6):450-7. PubMed ID: 23891495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.